New trials and therapies for acute myocardial infarction.

Gumina RJ
Med Clin North Am. 2007 91 (4): 729-49; xii

PMID: 17640545 · DOI:10.1016/j.mcna.2007.04.003

Acute coronary syndromes (ACSs), which include the clinical entities of unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), account for more than 1.5 million hospital admissions annually in the United States alone. Approximately 1 million of these admissions are classified as UA/NSTEMI and approximately 500,000 are STEMI. Because of the overwhelming number of studies on ACSs over the past several years, this article focuses on new trials and therapies for treating patients diagnosed with STEMI.

MeSH Terms (14)

Angioplasty, Balloon, Coronary Anticoagulants Cardiovascular Agents Clinical Trials as Topic Humans Hypothermia, Induced Myocardial Infarction Oxygen Platelet Aggregation Inhibitors Platelet Glycoprotein GPIIb-IIIa Complex Shock, Cardiogenic Stents Thrombectomy Thrombolytic Therapy

Connections (1)

This publication is referenced by other Labnodes entities: